Joel Greenblatt - Gotham Asset Management
Holding/activity history for Ultragenyx Pharmaceutical In (RARE)
← All RARE superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $37.02–52.56 · VW $42.45i | SEC | |
| 2024 Q1 | 7,478 | <0.01 | $46.69 | $349,148 | SEC | ||
| 2023 Q4 | 7,478 | <0.01 | Buy | <0.01 | $31.52–49.93 · VW $38.63i | $357,598 | SEC |
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | $34.33–47.08 · VW $39.24i | SEC | |
| 2023 Q2 | 15,822 | 0.02 | Reduce 16.11% | <0.01 | $37.20–54.98 · VW $46.36i | $729,869 | SEC |
| 2023 Q1 | 18,861 | 0.02 | Add 107.67% | <0.01 | $35.72–49.31 · VW $43.32i | $756,326 | SEC |
| 2022 Q4 | 9,082 | 0.01 | Add 53.78% | <0.01 | $33.36–46.51 · VW $40.20i | $420,769 | SEC |
| 2022 Q3 | 5,906 | <0.01 | Buy | <0.01 | $39.55–68.68 · VW $50.89i | $245,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $102.90–175.00 · VW $135.82i | SEC | |
| 2020 Q4 | 1,546 | <0.01 | Buy | <0.01 | $82.43–179.65 · VW $119.09i | $214,000 | SEC |
| 2019 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $54.41–74.50 · VW $62.89i | SEC | |
| 2019 Q1 | 4,562 | <0.01 | Buy | <0.01 | $39.78–71.63 · VW $58.54i | $316,000 | SEC |